4 Polen Capital Idexx Laboratories Trades
Polen Capital acquired 696k Idexx Laboratories shares worth $388M. That's 2.48% of their equity portfolio (16th largest holding). Polen Capital started to build up the position in Idexx Laboratories in Q2 2025. Since then they sold 500k shares. The stake costed the investor $333M, netting the investor a gain of 16% so far.
News about Idexx Laboratories, Inc. and Polen Capital
IDEXX Laboratories (IDXX) Rebounded After Significant Drawdown From July Highs
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downl...
Should You Add IDEXX Laboratories (IDXX) to Your Portfolio?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of...
Brinker Capital Investments LLC Reduces Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Brinker Capital Investments LLC lessened its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 3.4% during the 4th quarter, Holdin...
LGT Capital Partners LTD. Decreases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
LGT Capital Partners LTD. trimmed its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.0% in the third quarter, according to its most recent...